BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
16.81
+0.21 (1.30%)
At close: Oct 29, 2025, 4:00 PM EDT
16.76
-0.04 (-0.27%)
After-hours: Oct 29, 2025, 5:51 PM EDT
BrainsWay Revenue
BrainsWay had revenue of $12.63M in the quarter ending June 30, 2025, with 26.26% growth. This brings the company's revenue in the last twelve months to $46.08M, up 26.50% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.
Revenue (ttm)
$46.08M
Revenue Growth
+26.50%
P/S Ratio
6.97
Revenue / Employee
$384,033
Employees
120
Market Cap
321.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.02M | 9.23M | 29.04% |
| Dec 31, 2023 | 31.79M | 4.61M | 16.96% |
| Dec 31, 2022 | 27.18M | -2.48M | -8.36% |
| Dec 31, 2021 | 29.66M | 7.60M | 34.46% |
| Dec 31, 2020 | 22.06M | -1.04M | -4.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BWAY News
- 1 day ago - BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025 - GlobeNewsWire
- 2 days ago - BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers - GlobeNewsWire
- 2 months ago - BrainsWay Targets Expansion of its Total Addressable Market through a Strategic Investment in Neuromodulation Systems Developer, Neurolief Ltd. - GlobeNewsWire
- 2 months ago - BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health - GlobeNewsWire
- 2 months ago - BrainsWay Ltd. (BWAY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BrainsWay Reports Second Quarter 2025 Financial Results and Operational Highlights - GlobeNewsWire
- 5 months ago - BrainsWay Reports Positive Results from Multicenter Randomized Study of Accelerated Deep TMS for Major Depressive Disorder (MDD) - GlobeNewsWire
- 5 months ago - BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego - GlobeNewsWire